Vivian R. Albert
-
- Growth Hormone and Insulin-like Growth Factors 6
- Genetics top 2%
- Molecular Biology top 5%
- Cell death mechanisms and regulation 9
- Receptor Mechanisms and Signaling 4
- Cancer Research top 5%
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- interferon and immune responses 3
-
- Amino Acid Enzymes and Metabolism 3
-
- Metabolism and Genetic Disorders 3
-
- Biotin and Related Studies 3
- Co-authors
- Michael G. RosenfeldHarry P. ElsholtzHolly A. IngrahamChristian NelsonMichael S. KapiloffRonald M. EvansLaura A. B. WilsonRodrigo Franco
- Partner nations
- United StatesJapanSwitzerland
In The Last Decade
Vivian R. Albert
40 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Endocrinology, Diabetes and Metabolism 1.2k
- Genetics 968
- Cellular and Molecular Neuroscience 567
- Molecular Biology 1.9k
- Cancer Research 324
Countries citing papers authored by Vivian R. Albert
This map shows the geographic impact of Vivian R. Albert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivian R. Albert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivian R. Albert more than expected).
Fields of papers citing papers by Vivian R. Albert
This network shows the impact of papers produced by Vivian R. Albert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivian R. Albert. The network helps show where Vivian R. Albert may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vivian R. Albert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2015 | 22 | |
| 3 | 2012 | 13 | |
| 4 | 2009 | 26 | |
| 5 | 2007 | 17 | |
| 6 | 2006 | 50 | |
| 7 | HGS-TR2J, an agonistic, TRAIL receptor 2 monoclonal antibody, actively and rapidly stimulates the TRAIL receptor pathway that leads to significant inhibition of tumor growth in human tumor cell lines in vitro and in vivo | 2005 | 2 |
| 8 | 2005 | 129 | |
| 9 | Development of sensitive and specific immunohistochemical assays for pro-apoptotic TRAIL-receptors | 2004 | 6 |
| 10 | Human agonistic anti-TRAIL receptor antibodies, HGS-ETR1 and HGS-ETR2, induce apoptosis in diverse hematological tumor lines | 2003 | 5 |
| 11 | 2003 | 78 | |
| 12 | 2002 | 205 | |
| 13 | 1996 | 25 | |
| 14 | 1995 | 10 | |
| 15 | 1990 | 357 | |
| 16 | 1990 | 187 | |
| 17 | 1988 | 8 | |
| 18 | 1987 | 313 | |
| 19 | 1983 | 42 | |
| 20 | 1981 | 3 |
About Vivian R. Albert
Vivian R. Albert is a scholar working on Behavioral Neuroscience, Biochemistry and Cancer Research, having authored 42 papers that have together received 3.5k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (9 papers), Growth Hormone and Insulin-like Growth Factors (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Receptor Mechanisms and Signaling (4 papers), interferon and immune responses (3 papers), Amino Acid Enzymes and Metabolism (3 papers), Metabolism and Genetic Disorders (3 papers) and Biotin and Related Studies (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.2k citations), Genetics (968 citations) and Cellular and Molecular Neuroscience (567 citations). Vivian R. Albert has collaborated with scholars based in United States, Japan and Switzerland. Frequent co-authors include Michael G. Rosenfeld, Harry P. Elsholtz, Holly A. Ingraham, Christian Nelson, Michael G. Rosenfeld, Michael S. Kapiloff, Ronald M. Evans, Laura A. B. Wilson, Rodrigo Franco and Christine Jaeger. Their work appears in journals such as Nature, Science, Journal of Biological Chemistry, Cancer Research and Journal of Neurochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.